Growth Metrics

Jazz Pharmaceuticals (JAZZ) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -13.32%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 17.12%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -10.19%
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 24.11%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 12.18%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 3.92%
10 Jazz Pharmaceuticals 14.35 Bn 12.51 Bn 934.80 Mn 13.55%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 13.55%
Dec 31, 2025 15.27%
Sep 30, 2025 7.08%
Jun 30, 2025 9.27%
Mar 31, 2025 7.60%
Dec 31, 2024 2.22%
Sep 30, 2024 -20.70%
Jun 30, 2024 -26.16%
Mar 31, 2024 -26.95%
Dec 31, 2023 -25.61%
Sep 30, 2023 2.84%
Jun 30, 2023 -4.28%
Mar 31, 2023 -11.68%
Dec 31, 2022 -11.21%
Sep 30, 2022 -15.16%
Jun 30, 2022 -13.55%
Mar 31, 2022 108.00%
Dec 31, 2021 100.76%
Sep 30, 2021 98.91%
Jun 30, 2021 116.02%
Mar 31, 2021 -4.40%
Dec 31, 2020 -2.72%
Sep 30, 2020 -0.98%
Jun 30, 2020 0.85%
Mar 31, 2020 14.65%
Dec 31, 2019 -34.36%
Sep 30, 2019 -34.63%
Jun 30, 2019 -32.38%
Mar 31, 2019 -36.84%
Dec 31, 2018 17.80%
Sep 30, 2018 24.26%
Jun 30, 2018 37.66%
Mar 31, 2018 49.21%
Dec 31, 2017 58.23%
Sep 30, 2017 59.55%
Jun 30, 2017 46.16%
Mar 31, 2017 38.17%
Dec 31, 2016 25.61%
Sep 30, 2016 19.71%
Jun 30, 2016 16.22%
Mar 31, 2016 21.75%
Dec 31, 2015 46.62%
Sep 30, 2015 88.78%
Jun 30, 2015 109.11%
Mar 31, 2015 137.23%
Dec 31, 2014 309.68%
Sep 30, 2014 266.54%
Jun 30, 2014 257.19%
Mar 31, 2014 285.48%
Dec 31, 2013 95.66%
Sep 30, 2013 80.78%
Jun 30, 2013 132.52%
Mar 31, 2013 284.75%
Dec 31, 2012 367.63%
Sep 30, 2012 617.31%
Jun 30, 2012 615.77%
Dec 31, 2011 125.65%